Ethics and HIV prevention research: An analysis of the early tenofovir PrEP trial in Nigeria

In 2004, the first ever multi-sited clinical trials studied the prospect of HIV biomedical prevention (referred to as pre-exposure prophylaxis—‘PrEP’). The trials were implemented at several international sites, but many officially closed down before they completed. At most sites, both scientists an...

Full description

Saved in:  
Bibliographic Details
Authors: LaCelle-Peterson, Kristina 1960- (Author) ; Folayan, Morenike O. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Wiley-Blackwell [2019]
In: Bioethics
Year: 2019, Volume: 33, Issue: 1, Pages: 35-42
IxTheo Classification:KBN Sub-Saharan Africa
NCH Medical ethics
NCJ Ethics of science
Further subjects:B community engagement mechanisms
B Ethics
B HIV prevention
B PrEP
B Public private partnerships
B Nigeria
B Clinical Trials
Online Access: Presumably Free Access
Volltext (Verlag)
Volltext (doi)
Description
Summary:In 2004, the first ever multi-sited clinical trials studied the prospect of HIV biomedical prevention (referred to as pre-exposure prophylaxis—‘PrEP’). The trials were implemented at several international sites, but many officially closed down before they completed. At most sites, both scientists and community AIDS advocates raised concerns over the ethics and scientific rationales of the trial. Focusing on the Nigerian trial site, we detail the controversy that emerged among mostly Nigerian research scientists who scrutinized the research design and protocol. While some of the disputes, especially those pertaining to community engagement mechanisms, were ultimately resolved in international fora and implemented in later PrEP trials, concerns over science rationales and assumptions were never addressed. We argue that scientific rationales should be treated as ethical concerns and suggest that such concerns should be deliberated at host sites before the trial protocol is finalized.
ISSN:1467-8519
Contains:Enthalten in: Bioethics
Persistent identifiers:DOI: 10.1111/bioe.12470